Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir ‐ potential influence of censored observation
Alimentary Pharmacology & Therapeutics · 2024
DOI: 10.1111/apt.17767 ↗Kurz gefasst
Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2024. Verfasst von Ying-Nan Tsai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Antiviral Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
LINKED CONTENT This article is linked to Chen et al papers. To view these articles, visit https://doi.org/10.1111/apt.17602 and https://doi.org/10.1111/apt.17788
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan.
- School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
- Department of Public Health, National Cheng Kung University, College of Medicine, Tainan, Taiwan.
- Division of Gastroenterology and Hepatology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
ORCID-Profile: Ying-Nan Tsai
Zitieren
APA
Tsai, Y. N., Wu, J. L., & Hsu, Y. C. (2024). Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir ‐ potential influence of censored observation. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17767
Vancouver
Tsai YN, Wu JL, Hsu YC. Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir ‐ potential influence of censored observation. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.17767
BibTeX
@article{Tsai2024,
author = {Tsai, Ying-Nan and Wu, Jia-Ling and Hsu, Yao-Chun},
title = {Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir ‐ potential influence of censored observation},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
doi = {10.1111/apt.17767}
}
EUVIMED